Psychotic-like experiences in the general population: characterizing a high-risk group for psychosis

Psychological Medicine
I Kelleher, M Cannon

Abstract

Recent research shows that psychotic symptoms, or psychotic-like experiences (PLEs), are reported not only by psychosis patients but also by healthy members of the general population. Healthy individuals who report these symptoms are considered to represent a non-clinical psychosis phenotype, and have been demonstrated to be at increased risk of schizophrenia-spectrum disorder. Converging research now shows that this non-clinical psychosis phenotype is familial, heritable and covaries with familial schizophrenia-spectrum disorder. A review of the research also shows that the non-clinical phenotype is associated extensively with schizophrenia-related risk factors, including social, environmental, substance use, obstetric, developmental, anatomical, motor, cognitive, linguistic, intellectual and psychopathological risk factors. The criterion and construct validity of the non-clinical psychosis phenotype with schizophrenia demonstrates that it is a valid population in which to study the aetiology of psychosis. Furthermore, it suggests shared genetic variation between the clinical and non-clinical phenotypes. Much remains to be learned about psychosis by broadening the scope of research to include the non-clinical psychosis phenotype.

References

Feb 1, 1992·Psychological Medicine·M Shepherd
Feb 2, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Louise C JohnsElizabeth Kuipers
May 27, 2003·Schizophrenia Research·Janneke SpauwenJim van Os
May 18, 2004·Schizophrenia Research·Jack J BlanchardAlan S Bellack
Jul 22, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·Takahiro YoshizumiTakashi Murakami
Oct 2, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Louise C JohnsHoward Meltzer
Jul 12, 2005·The British Journal of Clinical Psychology·Manon HanssenJim van Os
Sep 10, 2005·Schizophrenia Bulletin·Lydia Krabbendam, Jim van Os
Nov 25, 2005·Schizophrenia Bulletin·Mary Catherine ClarkeMary Cannon
Jun 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·Nicola J WilesGlyn Lewis
Aug 30, 2006·Psychological Medicine·Paul FearonUNKNOWN AESOP Study Group
Jan 19, 2007·Behaviour Research and Therapy·Michelle L C Campbell, Anthony P Morrison
Jun 3, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Jouko MiettunenJuha Veijola
Sep 2, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Jeremy HorwoodGlynn Harrison
Nov 4, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Ian KelleherMary Cannon
Feb 21, 2009·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Tineke LatasterJim van Os
May 27, 2009·Schizophrenia Bulletin·Paolo Scotti
Apr 7, 2010·Archives of General Psychiatry·Guilherme PolanczykAvshalom Caspi

❮ Previous
Next ❯

Citations

Sep 18, 2012·European Child & Adolescent Psychiatry·Mamoru TochigiTsukasa Sasaki
Jun 7, 2011·Current Psychiatry Reports·Neely Laurenzo Myers
Jun 16, 2011·Psychological Medicine·Antonio PretiAndrea Raballo
Jul 14, 2012·Epidemiology and Psychiatric Sciences·S SahaJ McGrath
Feb 15, 2012·Proceedings of the National Academy of Sciences of the United States of America·Martin H TeicherAnn Polcari
Nov 13, 2012·Cognitive Neuropsychiatry·Abbie L Coy, Samuel B Hutton
Dec 12, 2012·Behavioral Sleep Medicine·Leslie M SwansonJ Todd Arnedt
Aug 17, 2010·Schizophrenia Bulletin·Jamie MurphyGary Adamson
May 12, 2011·Schizophrenia Bulletin·Frauke Schultze-LutterStephan Ruhrmann
Sep 1, 2011·Schizophrenia Bulletin·Madiha ShaikhElvira Bramon
Nov 26, 2011·Schizophrenia Bulletin·Nicholas C StefanisDaniel R Weinberger
Jan 1, 2011·Biology of Mood & Anxiety Disorders·Anja StuhrmannUdo Dannlowski
Aug 1, 2012·PloS One·Anna-Maija TolppanenDebbie A Lawlor
Sep 11, 2013·PloS One·Eduardo Fonseca-PedreroJosé Muñiz
Jan 18, 2014·Schizophrenia Bulletin·Ian Kelleher, Mary Cannon
Oct 26, 2013·Schizophrenia Research·Vijay A MittalTina Gupta
Apr 22, 2014·Psychiatry Research·Andrea Pelletier-BaldelliVijay A Mittal
Sep 4, 2014·Genetic Testing and Molecular Biomarkers·Dagmar BruenigJoanne Voisey
Nov 1, 2013·Schizophrenia Bulletin·Stanley ZammitMichael C O'Donovan
Apr 14, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Ian KelleherMary Cannon
Oct 16, 2012·Child Psychiatry and Human Development·Daniel MamahDavid M Ndetei
Jan 12, 2013·Social Psychiatry and Psychiatric Epidemiology·Katherine G Jonas, Kristian E Markon
Jul 25, 2012·Journal of Mental Health·Ulrike Schmidt, Til Wykes
Jun 21, 2012·Journal of Mental Health·Paul Wicks

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.